Clinical trials of Cuba’s Mambisa vaccine candidate are advancing
Havana, Jan 24.- The first clinical studies of the application of Cuba’s first nasal vaccine candidate, named Mambisa, to patients convalescing from Covid-19 and as a booster are ongoing.
Read More